GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicamen Biotech Ltd (BOM:531146) » Definitions » Total Inventories

Medicamen Biotech (BOM:531146) Total Inventories : ₹0 Mil (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Medicamen Biotech Total Inventories?

Medicamen Biotech's total inventories for the quarter that ended in Dec. 2024 was ₹0 Mil. Medicamen Biotech's average total inventories from the quarter that ended in Sep. 2024 to the quarter that ended in Dec. 2024 was ₹300 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Medicamen Biotech's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was ₹N/A.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Medicamen Biotech's Days Inventory for the three months ended in Dec. 2024 was 122.58.

Inventory Turnover measures how fast the company turns over its inventory within a year. Medicamen Biotech's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.74.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Medicamen Biotech's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.66.


Medicamen Biotech Total Inventories Historical Data

The historical data trend for Medicamen Biotech's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicamen Biotech Total Inventories Chart

Medicamen Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 169.58 52.04 270.10 450.57 593.75

Medicamen Biotech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 593.75 - 599.70 -

Medicamen Biotech Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Medicamen Biotech  (BOM:531146) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Medicamen Biotech's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

Net-Net Working Capital Per Share (Q: Dec. 2024 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0+0.75 * 0+0.5 * 0-N/A
-0-0)/12.715
=N/A

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Medicamen Biotech's Days Inventory for the three months ended in Dec. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2024 )/Cost of Goods Sold (Q: Dec. 2024 )*Days in Period
=299.8485/223.207*365 / 4
=122.58

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Medicamen Biotech's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2024 ) / Average Total Inventories (Q: Dec. 2024 )
=223.207 / 299.8485
=0.74

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Medicamen Biotech's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=299.8485 / 451.422
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Medicamen Biotech Total Inventories Related Terms

Thank you for viewing the detailed overview of Medicamen Biotech's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicamen Biotech Business Description

Traded in Other Exchanges
Address
1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, IND, 110019
Medicamen Biotech Ltd is an Indian based pharmaceutical company. The company is engaged in developing and manufacturing Pharmaceuticals formulations products. It manufactures Tablets, Capsules, Oral liquids, Dry syrups, Ointments, and Oral rehydration solution. The company generates revenue from the sale of pharmaceutical products.

Medicamen Biotech Headlines

No Headlines